Business Context and Reporting Period
This Form 6-K was filed by I-MAB, a foreign private issuer, for the month of September 2020. The filing was signed and dated September 22, 2020. The submitted text identifies I-MAB as the registrant, not Novabridge Biosciences.
The filing is a cover report and references Exhibit 99.1, a press release, but the press release text is not included in the provided source.
Financial and Operating Metrics
The provided filing text does not contain revenue, profit or loss, cash flow, margins, debt, liquidity, operating results, or other financial metrics.
Material Changes Versus Prior Period
The filing text does not provide comparative-period information or disclose material changes in financial or operating performance.
Guidance, Outlook, Risks, and Unusual Items
The filing text does not provide guidance, outlook, management commentary, risk disclosures, contingencies, or unusual items. Any such information may be contained in the referenced but unavailable Exhibit 99.1 press release.
Facts for Investor Verification
- Verify the issuer identity: the filing names I-MAB and lists Commission File Number 001-39173.
- Obtain and review Exhibit 99.1, the referenced press release.
- Confirm whether the requested company name, Novabridge Biosciences, corresponds to the filing, because it does not match the registrant named in the source.
- Review the issuer’s Form 20-F and other filings for financial results, liquidity, debt, risks, and outlook.